title: Ovarian failure with thalidomide treatment in complex aphthosis: comment on the concise communication by Ordi et al.
authors.forename: A
authors.initials: A
authors.lastname: Gompel
authors.forename: C
authors.initials: C
authors.lastname: Frances
authors.forename: J C
authors.initials: JC
authors.lastname: Piette
authors.forename: A S
authors.initials: AS
authors.lastname: Blanc
authors.forename: F
authors.initials: F
authors.lastname: Cordoliani
authors.forename: A M
authors.initials: AM
authors.lastname: Piette
mesh_terms: D000328:Adult; D000568:Amenorrhea / Q000139:chemically induced*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D008177:Lupus Vulgaris / Q000188:drug therapy*; D010053:Ovary / Q000187:drug effects / Q000503:physiopathology; D013281:Stomatitis, Aphthous / Q000188:drug therapy*; D013792:Thalidomide / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D007166:Immunosuppressive Agents; D013792:Thalidomide